Short description
ProFibrix is a biotech company developing and commercializing products for the hemostasis and regenerative medicine markets.
Description
ProFibrix B.V., a biotech company, creates, develops, and markets products for the hemostasis and regenerative medicine markets. Its products include Fibrocaps, a dry powder topical hemostat and tissue sealant based on a mixture of fibrinogen and thrombin, which stops acute and severe bleeding during surgery or in connection with trauma injury. The company also provides a sterilized single-use delivery device to deliver Fibrocaps to the target tissue area without the need to manipulate the wound in a surgical environment. It offers its products based on human fibrinogen, a natural blood protein for haemostasis, blood clotting, and tissue repair and healing. ProFibrix B.V. was founded in 2004
Last funding
Blurry Noaccess
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Leiden, Zuid-Holland, The Netherlands, Europe
Founded on
January 1, 2004
Closed on
August 5, 2013
Exited on
August 5, 2013
Non-profit?
No
Acquired?
No
Employees count
11-50
Investors
Cannot Access, Blurry Noaccess, Noaccess, Blurry Noaccess
Sign in for full access
Founders
Jaap Koopman